Evidence map›Paper›PMID 36700782›Full record

ArticleAnnals of surgery2023

Opioid Use After Gastric Bypass, Sleeve Gastrectomy or Intensive Lifestyle Intervention.

Stefan Wallén, Gustaf Bruze, Johan Ottosson, Claude Marcus, Johan Sundström, Eva Szabo, Torsten Olbers, Maria Palmetun-Ekbäck, Ingmar Näslund, Martin Neovius

Open access · greenAbstract read
In one paragraph

Article in Annals of surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Stefan WallénDepartment of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Gustaf BruzeDepartment of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Johan OttossonDepartment of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Claude MarcusDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Johan SundströmDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Eva SzaboDepartment of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Torsten OlbersInstitute of Clinical and Experimental Medicine and Wallenberg Centre for Molecular Medicine, University of Linköping and Department of Surgery, Vrinnevi, Norrköping, Sweden.
Maria Palmetun-EkbäckPharmacology and Therapeutic Department, Region Örebro County, University Hospital of Örebro, Sweden.
Ingmar NäslundDepartment of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Martin NeoviusDepartment of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Örebro University · SEKarolinska Institutet · SEUppsala University · SE

Funding

Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies.R01DK105948 · NIDDK · GOTEBORG UNIVERSITY · PI CARLSSON EKANDER, LENA, NEOVIUS, MARTIN · 2015 to 2018
$1.8M
NIDDK NIH HHS R01 DK105948
6 · The paper itself

Abstract

objectiveTo compare opioid use in patients with obesity treated with bariatric surgery versus adults with obesity who underwent intensive lifestyle modification. SUMMARY OF BACKGROUND DATA: Previous studies of opioid use after bariatric surgery have been limited by small sample sizes, short follow-up, and lack of control groups.

methodsNationwide matched cohort study including individuals from the Scandinavian Obesity Surgery Registry and the Itrim health database with individuals undergoing structured intensive lifestyle modification, between August 1, 2007 and September 30, 2015. Participants were matched on Body Mass Index, age, sex, education, previous opioid use, diabetes, cardiovascular disease, and psychiatric status (n = 30,359:21,356). Dispensed opioids were retrieved from the Swedish Prescribed Drug Register from 2 years before to up to 8 years after intervention.

resultsDuring the 2-year period before treatment, prevalence of individuals receiving ≥1 opioid prescription was identical in the surgery and lifestyle group. At 3 years, the prevalence of opioid prescriptions was 14.7% versus 8.9% in the surgery and lifestyle groups (mean difference 5.9%, 95% confidence interval 5.3-6.4) and at 8 years 16.9% versus 9.0% (7.9%, 6.8-9.0). The difference in mean daily dose also increased over time and was 3.55 mg in the surgery group versus 1.17 mg in the lifestyle group at 8 years (mean difference [adjusted for baseline dose] 2.30 mg, 95% confidence interval 1.61-2.98).

conclusionsBariatric surgery was associated with a higher proportion of opioid users and larger total opioid dose, compared to actively treated obese individuals. These trends were especially evident in patients who received additional surgery during follow-up.

Indexed as

Bariatric SurgeryGastric BypassObesity, MorbidOpioid-Related DisordersAdultAnalgesics, OpioidCohort StudiesGastrectomyHumansLife StyleObesityAnalgesics, Opioid

Identifiers

PMID36700782
PMCPMC9905206
OpenAlexW3198006350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.